4SCAR-CD44v6 T Cell Therapy Targeting Cancer

  • STATUS
    Recruiting
  • participants needed
    100
  • sponsor
    Shenzhen Geno-Immune Medical Institute
Send
Updated on 5 August 2020
See if I qualify

Summary

The purpose of this clinical trial is to assess the feasibility, safety and efficacy of 4SCAR-CD44v6 T-cell therapy targeting multiple cancers. The study also aims to learn more about the function of the CD44v6 CAR-T cells and their persistency in the patients.

Description

CD44 variant domain 6 (CD44v6) which belongs to CD44 family has been implicated in tumorigenesis, tumor cell invasion and metastasis. The expression of CD44v6 was reported for the majority of squamous cell carcinomas, a proportion of adenocarcinomas of differing origin, a proportion of melanoma and lymphoma. This expression pattern has made CD44v6 an attractive target for the therapy of various types of CD44v6 positive cancers.

The T cells from patients or transplantation donors will be genetically modified with lentiviral CAR vector to recognize specific molecules - CD44v6 expressed on the surface of the cancer cells. The engineered T cells will be applied to patients through intravenous delivery.

The purpose of this clinical trial is to assess the feasibility, safety and efficacy of CD44v6 CAR-T cell therapy in multiple cancers including - but not limited to - stomach cancer, breast cancer, prostate cancer, multiple myeloma and lymphoma which are CD44v6 positive. Another goal of the study is to learn more about the function of the 4SCAR-CD44v6 T cells and their persistency in the patients.

Details
Condition Cancers Which Are CD44v6 Positive
Age 1years - 75years
Treatment CD44v6-specific CAR gene-engineered T cells
Clinical Study IdentifierNCT04427449
SponsorShenzhen Geno-Immune Medical Institute
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Age older than 6 months
Confirmed expression of CD44v6 in tumor specimens by immuno-histochemical staining or flow cytometry
Karnofsky performance status (KPS) score is higher than 70 and life expectancy > 3 months
Adequate bone marrow, liver and renal function as assessed by the following laboratory requirements: cardiac ejection fraction 50%, oxygen saturation 90%, creatinine 2.5 upper limit of normal, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) 3 upper limit of normal, total bilirubin 2.0mg/dL
Hgb80g/L
No cell separation contraindications
Abilities to understand and the willingness to provide written informed consent

Exclusion Criteria

Sever illness or medical condition, which would not permit the patient to be managed according to the protocol, including active uncontrolled infection
Active bacterial, fungal or viral infection not controlled by adequate treatment
Known HIV, hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
Pregnant or nursing women may not participate
Use of glucocorticoid for systemic therapy within one week prior to entering the trial
Receive treatment related to CD44v6 targeted therapy
Patients, in the opinion of investigators, may not be able to comply with the study
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.